{
    "startDate": "2021-01-01",
    "endDate": "2021-03-31",
    "year": "2021",
    "quarter": "Q1",
    "symbol": "DYAI",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 13055558
            },
            {
                "label": "Short-term investment securities",
                "concept": "HeldToMaturitySecuritiesCurrent",
                "unit": "usd",
                "value": 14177441
            },
            {
                "label": "Interest receivable",
                "concept": "InterestReceivableCurrent",
                "unit": "usd",
                "value": 157201
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 384963
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 216189
            },
            {
                "label": "us-gaap_AssetsCurrent",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 27991352
            },
            {
                "label": "Investment in Alphazyme",
                "concept": "dyai:PrepaidResearchAndDevelopmentInProcessCurrent",
                "unit": "usd",
                "value": 284709
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 6151
            },
            {
                "label": "us-gaap_AssetsCurrent",
                "concept": "Assets",
                "unit": "usd",
                "value": 28282212
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1473813
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 277668
            },
            {
                "label": "Deferred research and development obligations",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 842248
            },
            {
                "label": "us-gaap_LiabilitiesCurrent",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 2593729
            },
            {
                "label": "Commitments and contingencies (Note 4)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $.0001 par value: Authorized shares - 5,000,000; none issued and outstanding",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $.001 par value: Authorized shares - 100,000,000; issued shares - 39,807,659 and 39,747,659, outstanding shares - 27,554,157 and 27,494,157 as of March 31, 2021 and December 31, 2020, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 39808
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 98549890
            },
            {
                "label": "us-gaap_TreasuryStockValue",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 18929915
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -53971300
            },
            {
                "label": "Stockholders' Equity Note Disclosure [Text Block]",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 25688483
            },
            {
                "label": "us-gaap_LiabilitiesAndStockholdersEquity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 28282212
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -3294949
            },
            {
                "label": "Risk-Free interest rate, maximum",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 421071
            },
            {
                "label": "Amortization of held-to-maturity securities, net",
                "concept": "InvestmentIncomeAmortizationOfPremium",
                "unit": "usd",
                "value": 63951
            },
            {
                "label": "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": -28272
            },
            {
                "label": "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet",
                "concept": "IncreaseDecreaseInAccruedInterestReceivableNet",
                "unit": "usd",
                "value": 44954
            },
            {
                "label": "us-gaap_IncreaseDecreaseInAccountsReceivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 131800
            },
            {
                "label": "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -64297
            },
            {
                "label": "us-gaap_IncreaseDecreaseInAccountsPayable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 480455
            },
            {
                "label": "us-gaap_IncreaseDecreaseInAccruedLiabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": -212088
            },
            {
                "label": "us-gaap_IncreaseDecreaseInContractWithCustomerLiability",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": 719232
            },
            {
                "label": "Cash flows from operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -1906513
            },
            {
                "label": "us-gaap_PaymentsToAcquireHeldToMaturitySecurities",
                "concept": "PaymentsToAcquireHeldToMaturitySecurities",
                "unit": "usd",
                "value": 11283940
            },
            {
                "label": "Proceeds from maturities of investment securities",
                "concept": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
                "unit": "usd",
                "value": 5500000
            },
            {
                "label": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -5783940
            },
            {
                "label": "Proceeds from exercise of options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 115800
            },
            {
                "label": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 115800
            },
            {
                "label": "Effect of exchange rate changes on cash",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "unit": "usd",
                "value": -6834
            },
            {
                "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -7581487
            }
        ],
        "ic": [
            {
                "label": "Research and development revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 460520
            },
            {
                "label": "Costs of research and development revenue",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 390762
            },
            {
                "label": "Research and Development Expense, Policy [Policy Text Block]",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 1808098
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 1554007
            },
            {
                "label": "us-gaap_ForeignCurrencyTransactionGainLossRealized",
                "concept": "ForeignCurrencyTransactionGainLossRealized",
                "unit": "usd",
                "value": -28272
            },
            {
                "label": "us-gaap_CostsAndExpenses",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 3781139
            },
            {
                "label": "us-gaap_OperatingIncomeLoss",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -3320619
            },
            {
                "label": "Interest income",
                "concept": "InterestIncomeExpenseNonoperatingNet",
                "unit": "usd",
                "value": 25670
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -3294949
            },
            {
                "label": "Basic and diluted net loss per common share (in dollars per share)",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.12
            },
            {
                "label": "Basic and diluted weighted-average common shares outstanding (in shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 27533268
            }
        ]
    }
}